Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

RTTNews | il y a 1150
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.

HT-TBI is being developed as a novel, point-of-care therapy for the treatment and/or prevention of secondary brain injury resulting from ischemic stroke and traumatic brain injury (TBI).

HT-TBI will be developed as a ready-to-use drug-device combination product for use in non-healthcare settings by patients and caregivers at risk for stroke/TBI, emergency healthcare professionals, and military personnel.

The HT-TBI formulation development and manufacturing work by Altasciences will be used to support a future Investigational New Drug (IND) Application to initiate clinical trials.

For More Such Health News, visit rttnews.com

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | il y a 794
DAX Retreats After Positive Start, Down Nearly 0.5%

DAX Retreats After Positive Start, Down Nearly 0.5%

German stocks are swinging between gains and losses in cautious trade on Thursday with investors digesting the news about U.S. President Donald Trump signing the short-term funding bill that brings an end to the government shutdown, and looking ahead to some key U.S. economic data.
RTTNews | il y a 1h 14min
Eurozone Industrial Production Rises Less Than Forecast

Eurozone Industrial Production Rises Less Than Forecast

Eurozone industrial production recovered at a moderate pace in September largely driven by the rebound in energy output, official data showed on Thursday. Industrial production grew at a slower-than-expected pace of 0.2 percent in September from August, Eurostat revealed. Output was forecast to grow 0.7 percent, reversing a 1.1 percent fall in August.
RTTNews | il y a 1h 24min
Sensex, Nifty Fail To Hold Early Gains, Settle Roughly Flat

Sensex, Nifty Fail To Hold Early Gains, Settle Roughly Flat

Despite a fairly strong spell in positive territory that lasted close to four hours, Indian equity benchmark Sensex and the Nifty50 settled just marginally up on Thursday as several stocks pared early gains due to a sell-off in the final hour of the day's trading session.
RTTNews | il y a 1h 41min
Asian Markets Close Mostly Higher

Asian Markets Close Mostly Higher

Broadly positive sentiment prevailed in Asian markets tracking the positive sentiment created by the end of the longest-ever U.S. government shutdown.
RTTNews | il y a 1h 57min
Euro Rises Amid Risk-On Mood

Euro Rises Amid Risk-On Mood

The euro strengthened against other major currencies in the pre-European session on Thursday as European shares traded higher, amid positive sentiment generated by the conclusion of the longest federal closure in U.S. history. An improved global risk sentiment and updates to earnings are seen swaying sentiment even as concerns about tech valuation lingered.
RTTNews | il y a 2h 25min